JoonyO
GLP-1 Enthusiast
here from the latest Reta trial results ( first I'd heard of it ) is what many of us refer to as allodynia? The descriptions sure sound similar.
www.biospace.com
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.